Serum biomarkers identify critically ill traumatic brain injury patients for MRI

MLA

Sophie Richter, et al. “Serum Biomarkers Identify Critically Ill Traumatic Brain Injury Patients for MRI.” Critical Care, vol. 26, no. 1, Nov. 2022, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s13054-022-04250-3.

APA

Sophie Richter, Stefan Winzeck, Endre Czeiter, Krisztina Amrein, Evgenios N. Kornaropoulos, Jan Verheyden, Gabriela Sugar, Zhihui Yang, Kevin Wang, Andrew I. R. Maas, Ewout Steyerberg, András Büki, Virginia F. J. Newcombe, David K. Menon, & the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Magnetic Resonance Imaging (CENTER-TBI MRI) Sub-study Participants and Investigators. (2022). Serum biomarkers identify critically ill traumatic brain injury patients for MRI. Critical Care, 26(1), 1–7. https://doi.org/10.1186/s13054-022-04250-3

Chicago

Sophie Richter, Stefan Winzeck, Endre Czeiter, Krisztina Amrein, Evgenios N. Kornaropoulos, Jan Verheyden, Gabriela Sugar, et al. 2022. “Serum Biomarkers Identify Critically Ill Traumatic Brain Injury Patients for MRI.” Critical Care 26 (1): 1–7. doi:10.1186/s13054-022-04250-3.